Markets:

Overview

News

Currencies

International

Treasuries

Stryker Corp (NY:SYK)

359.08 -1.98 (-0.55%)

Streaming Delayed Price Updated: 10:51 AM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest

February 28, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at medical devices & supplies - diversified...

Via StockStory

Q4 Earnings Roundup: Baxter (NYSE:BAX) And The Rest Of The Medical Devices & Supplies - Diversified Segment

February 25, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how medical devices & supplies - diversified stocks fared in Q4,...

Via StockStory

Q4 Earnings Highs And Lows: Neogen (NASDAQ:NEOG) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks

February 24, 2025

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Neogen (NASDAQ:NEOG) and its peers.

Via StockStory

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today ↗

February 21, 2025

Via Benzinga

Analyst Expectations For Stryker's Future ↗

February 18, 2025

Via Benzinga

Peering Into Stryker's Recent Short Interest ↗

February 12, 2025

Via Benzinga

$100 Invested In Stryker 10 Years Ago Would Be Worth This Much Today ↗

February 04, 2025

Via Benzinga

Stryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segment

February 19, 2025

From Stryker Corporation

Via GlobeNewswire

Baxter Earnings: What To Look For From BAX

February 19, 2025

Healthcare company Baxter International (NYSE:BAX) will be reporting earnings tomorrow morning. Here’s what investors should know.

Via StockStory

Stryker to participate in Citi’s 2025 Unplugged Medtech and Life Sciences Access Day

February 13, 2025

From Stryker Corporation

Via GlobeNewswire

What To Expect From Baxter’s (BAX) Q4 Earnings

February 12, 2025

Healthcare company Baxter International (NYSE:BAX) will be announcing earnings results tomorrow morning. Here’s what investors should know.

Via StockStory

A Glimpse Into The Expert Outlook On Stryker Through 14 Analysts ↗

January 29, 2025

Via Benzinga

Stryker Earnings Report: Q4 Overview ↗

January 28, 2025

Via Benzinga

Stryker Earnings Review: Q4 Summary ↗

January 28, 2025

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

February 11, 2025

Via Benzinga

Stryker announces Allan Golston will retire from Board of Directors

February 10, 2025

From Stryker Corporation

Via GlobeNewswire

Q4 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Boston Scientific (NYSE:BSX)

February 10, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Boston Scientific (NYSE:BSX) and the best...

Via StockStory

Stryker Earnings Analysis: Q4 Recap ↗

January 28, 2025

Via Benzinga

Stryker Q4 Earnings Assessment ↗

January 28, 2025

Via Benzinga

Insights into Stryker Q4 Earnings ↗

January 28, 2025

Via Benzinga

Jim Cramer: This Health Care Stock Is A 'Winner,' Buy Bitcoin Instead Of Coinbase ↗

February 05, 2025

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying AbbVie Inc. (NYSE:ABBV), saying it's “just a gem” and a “winner.” He added, “I can't believe the stock dropped so much.”

Via Benzinga

Stryker declares an $0.84 per share quarterly dividend

February 05, 2025

From Stryker Corporation

Via GlobeNewswire

Stryker (NYSE:SYK) Posts Better-Than-Expected Sales In Q4

January 31, 2025

Medical technology company Stryker (NYSE:SYK) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 10.7% year on year to $6.44 billion. Its non-GAAP profit of $4.01 per...

Via StockStory

Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and NARI Deal Set to Drive Future Growth ↗

January 29, 2025

Wall Street analysts upgraded Stryker Corp (NYSE: SYK) after its Q4 report beat expectations, with strong sales and earnings growth projected for 2025.

Via Benzinga

Earnings Summary: Stryker Q4 ↗

January 28, 2025

Via Benzinga

Starbucks To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

January 29, 2025

Via Benzinga

US Futures Point To Cautious Start As Investors Await Fed's Rate Decision: Tesla, Microsoft, Meta Among Stocks In Focus Ahead Of Earnings ↗

January 29, 2025

U.S. stock futures were mixed ahead of the crucial earnings from key U.S. technology companies and the Fed's expected pause on rate cuts.

Via Benzinga

Topics Economy

Tesla, Starbucks And 3 Stocks To Watch Heading Into Wednesday ↗

January 29, 2025

Via Benzinga

Stryker Undercuts Breakout On Sales Deal, Despite Quarterly Beat ↗

January 28, 2025

Stryker stock dipped late Tuesday after the medtech company beat forecasts, but announced its plan to divest the U.S. spinal business.

Via Investor's Business Daily

Stryker announces the retirement of Glenn S. Boehnlein and the promotion of Preston Wells to Vice President, Chief Financial Officer

January 28, 2025

From Stryker Corporation

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.